Disease-specific survivalA competing risks analysis was undertaken to identify subgroups at greatest risk of dying from prostate cancer (PC) after definitive external beam radiation therapy (RT)卤androgen deprivation therapy (ADT) in the prostate specific antigen (PSA) era. Outcomes of 2675 men with...
Prostate cancer is a major cause of cancer morbidity and mortality. Intra-prostatic inflammation is a risk factor for prostate carcinogenesis, with diet, chemical injury and an altered microbiome being causally implicated. Intra-prostatic inflammatory ce
WebMD's slideshow covers prostate cancer: who's at risk, symptoms, tests, staging, treatments, survival, and foods that may help lower your risk for prostate cancer.
This cohort study examines the overall survival in men with very high-risk prostate cancer who are treated with radiotherapy and hormone therapy at
The improved survival was observed for ages 50 years or older, both White patients and Black patients, all tumour stages and grades. This was also demonstrated despite the receipt of surgery or radiation treatment. Conclusions MHS beneficiaries with advanced prostate cancer had longer survival than ...
Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many me
The Cell Cycle Inhibitors p21WAF1 and p27KIP1 Are Associated with Survival in Patients Treated by Salvage Prostatectomy after Radiation Therapy radical prostatectomy and bilateral pelvic lymphadenectomy for biopsy-proven locally persistent or recurrent prostate cancer after external beam radiation therapy. ....
"While this trial may not be practice changing, it certainly adds validity to the notion that treatment of prostate cancer can lead to some patient harm (particularly sexual dysfunction and urinary incontinence after radical prostatectomy and rectal bleeding after radiation therapy)," he added. ...
Localized prostate cancer bPFS: Biological prostate-specific antigen relapse-free survival rate IntraPM: Intrafractional prostate motion InterPM: Interfractional prostate motion IGRT: Image-guided radiotherapy HR: High risk EMT: Electromagnetic transponders Linac: Linear accelerator MRI: Magnetic...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of these; also systematic reanalysis of public miR-profile...